The effect of a synbiotic (probiotic and prebiotic) supplementation on patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A proof of concept study

Durdans Hospital, 3, Alfred place, Colombo 30 个研究点开始时间: 待定最近更新: 2024年8月20日

适应症

试验速览

暂无简介。

•Subjects who are diagnosed to have NAFLD by a medical officer or a medical consultant [based on hepatic ultrasonography and elevated levels (>1.5xUpper Limit) of alanine aminotransferase (ALT) concentration] and are referred to a registered Dietician & Nutritionist.
•Age between 30-55 years

•Subjects having other acute or chronic liver diseases of other etiologies (viral hepatitis, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, hereditary haemochromatosis, Wilson's disease, drug induced liver injury; cholestasis).
•Subjects who are pregnant and / or lactating
•Subjects who have history of malignancy, history of significant alcohol consumption (>14 units/week for men, >7 units/week for females)
•Subjects who are taking antibiotics, probiotics, vitamin, mineral, antioxidants, omega-3 or any other food supplements preceding enrollment
•Subjects who are on treatment with vitamin E, statins within 3 months prior to the starting date of the research.

发起方

Durdans Hospital, 3, Alfred place, Colombo 3